Tier 4 — mechanistic

Betaine in Inflammation: Mechanistic Aspects and Applications

Guangfu Zhao, Fang He, Chenlu Wu, Pan Li, Nengzhang Li, Jinping Deng, Guoqiang Zhu, Wenkai Ren, Yuanyi Peng
Frontiers in immunology 2018 9:1070

Bibliography

PubMed
PMID 29881379
PubMed Central
PMC5976740
DOI
10.3389/fimmu.2018.01070
Funding
Funding was not specified in the indexed record or accessible funding metadata.
Competing interests
Reported disclosure: This work is supported by the earmarked fund of the China Agriculture Research System (Beef/Yak Cattle, CARS-37) and the Chongqing Science & Technology Commission (cstc2016shmszx80085, cstc2017jcyjAX0288). Conflict of Interest StatementThe authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as potential conflicts of interest.

Study snapshot

DesignNarrative review
ModelEvidence synthesis; mixed research models
SamplePublished literature; no newly enrolled participant cohort
InterventionReview of betaine-related evidence; no single assigned intervention
DurationEvidence review; source-specific study durations vary
EndpointsBetaine biology; Clinical and mechanistic evidence

What the study showed, in plain terms

Published in 2018, this source examined mechanistic and clinical reviews. Its evidence base was Published literature; no newly enrolled participant cohort. It evaluated Review of betaine-related evidence; no single assigned intervention across Evidence review; source-specific study durations vary.

Describes possible effects on NF-kappaB, NLRP3, oxidative stress and inflammatory signaling.

Mechanistic literature does not establish consistent clinical anti-inflammatory efficacy; later human meta-analysis is more cautious.

Continue with TMG Data Center

Continue with TMG Supplement: Trimethylglycine Benefits, Uses and Evidence

Key findings

  • Describes possible effects on NF-kappaB, NLRP3, oxidative stress and inflammatory signaling.
  • The recorded outcome domains were Betaine biology; Clinical and mechanistic evidence.

What this study can and cannot tell us

  • Mechanistic literature does not establish consistent clinical anti-inflammatory efficacy; later human meta-analysis is more cautious.
  • The conclusions inherit the limitations of the underlying studies. A narrative interpretation or guideline recommendation is not a new randomized treatment comparison.
  • Source basis: Accessible full-text extract plus indexed bibliographic data. Missing method details, funding information or participant denominators are not inferred.

Related papers in the corpus

Tier 4
Decoding Betaine: A Critical Analysis of Therapeutic Potential Compared with Marketing Hype-A Narrative Review
Grzegorz Nikrandt et al. · The Journal of nutrition · 2024
Tier 4
Beneficial Effects of Betaine: A Comprehensive Review
Madan Kumar Arumugam et al. · Biology · 2021
Tier 4
Betaine in human nutrition
Stuart A S Craig et al. · The American journal of clinical nutrition · 2004
Tier 4
Choline and betaine in health and disease
Per Magne Ueland et al. · Journal of inherited metabolic disease · 2011

Editorial review

Reviewed by the Biohack Blueprint research team

Last verified

Dr. Khaled Mahmoud, MBBChCritical Care Medicine, Longevity Science & Editorial Direction Dr. Amr Yasser, PhDCardiometabolic, Musculoskeletal, Gut & Bioavailability Dr. Abdulla Mostafa, PhDCellular Senescence, Neurological, Mitochondrial & Brain-Ageing Biology